The novel 5-HT1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  European Journal of Pharmacology

• Publication date

  1992-06-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(92)90433-5PMID 1425929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The novel 5-HT1A receptor antagonist (S)-UH-301 antagonizes 8-OH-DPAT-induced effects on male as well as female rat copulatory behaviour.

  1991cited by this paper
• Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.

  1991cited by this paper
• Effects of MDL 73005EF on central pre- and postsynaptic 5-HT1A receptor function in the rat in vivo.

  1990cited by this paper
• Cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors

  1990cited by this paper
• Mixed agonist/antagonist properties of NAN-190 at 5-HT1A receptors: behavioural and in vivo brain microdialysis studies.

  1990cited by this paper
• Characterization of MDL 73005EF as a 5‐HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8‐OH‐DPAT and diazepam

  1990cited by this paper
• (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist.

  1990cited by this paper
• Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor.

  1990cited by this paper
• Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.

  1990cited by this paper
• 5‐HT1 agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis

  1989cited by this paper
• Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis.

  1989cited by this paper
• Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis

  1989cited by this paper
• Serotonin release estimated by transcortical dialysis in freely-moving rats.

  1989cited by this paper
• Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis.

  1989cited by this paper
• In Vivo Measurement of Extracellular 5‐Hydroxytryptamine in Hippocampus of the Anaesthetized Rat Using Microdialysis: Changes in Relation to 5‐Hydroxytryptaminergic Neuronal Activity

  1989cited by this paper
• Pharmacological characterization of 8‐OH‐DPAT‐induced inhibition of rat hippocampal 5‐HT release in vivo as measured by microdialysis

  1989cited by this paper
• On the origin of dopamine and its metabolite in predominantly noradrenergic innervated brain areas.

  1985cited by this paper
• Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper

• 5-HT1A and 5-HT2A receptor effects on recognition memory, motor/exploratory behaviors, emotionality and regional dopamine transporter binding in the rat.

  2024influential citation
• The 5-HT1A receptor agonist 8-OH-DPAT modulates motor/exploratory activity, recognition memory and dopamine transporter binding in the dorsal and ventral striatum.

  2023cites this paper
• The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders

  2016cites this paper
• Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody.

  2006cites this paper
• Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: Raphé control of somatodendritic and terminal 5-HT release

  2005cites this paper
• The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum

  2005influential citation
• The 5-HT1A receptor antagonist (S)-UH-301 blocks the (R)-8-OH-DPAT-induced inhibition of serotonergic dorsal raphe cell firing in the rat

  2005cites this paper
• Changes in extracellular 5-HIAA concentrations as measured by in vivo microdialysis technique in relation to changes in 5-HT release

  2004cites this paper
• In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function.

  2004cites this paper
• Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice

  2003cites this paper
• Effects of Typical and Atypical Antipsychotics and Receptor Selective Compounds on Acetylcholine Efflux in the Hippocampus of the Rat

  2002cites this paper
• Autoregulation of serotonin neurons: role in antidepressant drug action.

  1999cites this paper
• A review of central 5-HT receptors and their function.

  1999cites this paper
• The medicinal chemistry of 2-aminotetralin-derived benzamides: a novel class of potential atypical antipsychotic agents

  1998cites this paper
• Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.

  1998cites this paper
• WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor.

  1997cites this paper
• The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.

  1997cites this paper
• Blockade of pre-and post-synaptic 5-HT1A receptors does not modify the effect of fluoxetine or 5-hydroxytryptophan on ethanol and food intake in rats

  1997cites this paper
• The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.

  1996cites this paper
• Derivatives of (R)- and (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: synthesis and interactions with 5-HT1A receptors.

  1996cites this paper
• Dissociations in Hippocampal 5‐Hydroxytryptamine Release in the Rat Following Pavlovian Aversive Conditioning to Discrete and Contextual Stimuli

  1996cites this paper
• Synthesis and pharmacology of the enantiomers of UH301: opposing interactions with 5-HT1A receptors.

  1996cites this paper
• The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram

  1996influential citation
• 5-HT1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus.

  1996cites this paper
• The corticosterone-enhancing effects of the 5-HT1A receptor antagonist, (S)-UH301, are not mediated by the 5-HT1A receptor.

  1995cites this paper
• Development of 5-HT1A receptor antagonists.

  1995cites this paper
• 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram

  1995cites this paper
• Drug Discovery and Chirality — Implications of Chirality for Structure-Activity Relationships in Drug Design

  1994cites this paper
• Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats.

  1994cites this paper
• Serotonin mechanisms in animal models of anxiety.

  1993cites this paper
• Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study.

  1993cites this paper
• WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors.

  1993cites this paper
• Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors.

  1993cites this paper
• WAY 100,135 and (-)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo.

  1993cites this paper
• The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons

  1993cites this paper
• Serotonin 5‐HT1A Autoreceptor Blockade Potentiates the Ability of the 5‐HT Reuptake Inhibitor Citalopram to Increase Nerve Terminal Output of 5‐HT In Vivo: A Microdialysis Study

  1993cites this paper
• In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol.

  1993cites this paper
• Synthesis of new derivatives of 8-OH-DPAT: influence of substitution on the aromatic ring on the pharmacological profile

  1993cites this paper
• Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents.

  1993cites this paper